...
首页> 外文期刊>Interdisciplinary perspectives on infectious diseases >Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets
【24h】

Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets

机译:疟原虫恶性疟原虫的丝氨酸蛋白酶:潜在作为抗疟药物的目标

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Malaria is a major global parasitic disease and a cause of enormous mortality and morbidity. Widespread drug resistance against currently available antimalarials warrants the identification of novel drug targets and development of new drugs. Malarial proteases are a group of molecules that serve as potential drug targets because of their essentiality for parasite life cycle stages and feasibility of designing specific inhibitors against them. Proteases belonging to various mechanistic classes are found in P. falciparum, of which serine proteases are of particular interest due to their involvement in parasite-specific processes of egress and invasion. In P. falciparum, a number of serine proteases belonging to chymotrypsin, subtilisin, and rhomboid clans are found. This review focuses on the potential of P. falciparum serine proteases as antimalarial drug targets.
机译:疟疾是一种主要的全球性寄生虫病,是造成巨大死亡率和发病率的原因。对目前可用的抗疟药的广泛耐药性确保了新药靶标的确定和新药的开发。疟疾蛋白酶是一组分子,可作为潜在的药物靶标,因为它们对寄生虫生命周期阶段至关重要,并且可以设计针对它们的特异性抑制剂。在恶性疟原虫中发现了属于各种机制类别的蛋白酶,丝氨酸蛋白酶特别受关注,因为它们参与了寄生虫特异性的侵袭和侵袭过程。在恶性疟原虫中,发现了许多胰凝乳蛋白酶,枯草杆菌蛋白酶和菱形氏族的丝氨酸蛋白酶。这篇综述集中于恶性疟原虫丝氨酸蛋白酶作为抗疟药靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号